BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 1998
View Archived Issues
IL-1 blockers CK-119 and CK-122 inhibit corneal fibroblast-like cell proliferation
Read More
Pivotal clinical trial data for rituximab published
Read More
Genzyme General and Knoll reach copromotion agreement for Thyrogen
Read More
Genset enters into Chlamydia vaccine license agreement with AHP
Read More
MDI-P demonstrates potent anti-HIV activity in preclinical studies
Read More
Scientists solve 3D structure of enzyme that confers bacterial resistance to gentamicin
Read More
Hoechst Marion Roussel and 3M file NDA for QVAR
Read More
MorphoSys and LeukoSite enter collaboration agreement
Read More
Novel antitumor antibiotics isolated from Streptomyces by Japanese researchers
Read More
P&G reports alpha2-adrenoceptor agonists for treating nasal congestion
Read More
T Cell Sciences-Virus Research Institute merger completed; Avant up and running
Read More
Ergo Science submits amendment to Ergoset NDA
Read More
Isis Pharmaceuticals: Q2 1998 highlights
Read More
Pharmacia & Upjohn: Q2 1998 highlights
Read More
NDA application submitted for Orphan Medical's Busulfex injection
Read More
Bayer reports new agents for treating cardiovascular disease
Read More
Wakunaga discloses new antibacterial agents in early development
Read More
New cephalosporin derivatives active against MRSA
Read More
Contrast agent from Nycomed Imaging proves useful for several applications
Read More
AR-C69931MX; a novel P2T antagonist with platelet aggregation-inhibitory activity
Read More
ETA antagonism with LU-135252 may provide novel antiischemic therapy
Read More
Preclinical and clinical data reported for orbofiban, a potent antiplatelet agent
Read More
News from the ACS: Roche synthesizes selective 5-HT2C antagonists
Read More
Profile of VPA-985, Wyeth-Ayerst's aquaretic agent in clinical trials
Read More
Another beta3-adrenergic agent added to the BMS pipeline
Read More
Proteus applies prion antibody technology to develop a test for CJD
Read More
Phase II study establishes feasibility, safety of pioneering restenosis treatment
Read More
News from the ACS: Lilly investigates antioxidants for treating neuronal injury
Read More
BioCryst identifies development candidate in complement inhibitor program
Read More
WAY-140288: a follow-up V2 antagonist and aquaretic agent from Wyeth-Ayerst
Read More
